Elektrofi is a biotechnology company focused on improving administration for a wide range of medicines including monoclonal antibodies, therapeutic proteins, and other large molecule drugs. Its breakthrough formulation platform enables stabilized, highly concentrated formulations for subcutaneous administration. The company is using this technology to transform therapies that are administered intravenously, and to enhance injectable products by reducing the volume and frequency of dosing. Elektrofi partners with pharmaceutical companies to jointly develop patient-friendly delivery solutions. Headquartered in Boston, the company’s founding team of MIT engineers and scientists are shaping the future of biologics delivery.
Location: United States, Massachusetts, Boston
Member count: 11-50
Total raised: $40M
Founded date: 2016
Investors 1
| Date | Name | Website |
| - | Charlotte ... | cltangelfu... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 13.06.2022 | Series B | $40M | BVF Partne... | finsmes.co... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 14.06.2022 | Boston sta... | As drug manufacturing star... | Financing | Tyler Patc... | endpts.com... |
| 13.06.2022 | Elektrofi ... | Elektrofi, a Boston, MA-based ... | USA | - | finsmes.co... |